Duopharma Biotech Bhd
7148 · KLSE · Healthcare / Drug Manufacturers - Specialty & Generic
Price History
Full chartMarket Stats
About
Duopharma Biotech Berhad, together with its subsidiaries, researches, develops, manufactures, markets, sells, imports, and distributes pharmaceutical products and medicines in Malaysia and internationally. It offers consumer healthcare products, including vitamins, minerals, and supplements under the Flavettes, PROVITON, PROVITON STR, CHAMPS, and Naturalle brand names; analgesics and antitussives under the Uphamol, Uphacol, and Uphaplast brand names; eyecare products under the Eye Glo brand name; antacids under the Alucid brand name; joint pain products under the Donna brand name; skincare products under Dermoplex brand name; cosmeceuticals under the IRORO Nutreatment brand name; and functional food under the CHAMPS Nutribar and PROVITON STR Powerz brand names. The company also provides generic drugs for various therapeutic areas, such as cardiovascular, dermatology, hormonal, respiratory, sensory and nervous system, musculoskeletal, anti-infectives, and others; and specialty pharmaceutical drugs for targeted conditions, biosimilar products, and medical devices and consumables for the treatment of diabetes, cancer, cardiovascular, renal, and other diseases. In addition, it engages in the development of small molecules and biologic therapies for the treatment of Alzheimer's disease; digital therapeutics; and stem cell therapies. Further, the company is involved in property management and services; and distribution of chemical products. It exports its products. The company was formerly known as CCM Duopharma Biotech Berhad and changed its name to Duopharma Biotech Berhad in February 2019. Duopharma Biotech Berhad was founded in 1978 and is headquartered in Kuala Lumpur, Malaysia.
Company Details
- SectorHealthcare
- IndustryDrug Manufacturers - Specialty & Generic
- CEOMr. Wan Amir-Jeffery Bin Wan Abdul Majid
- Employees1.96K
- HeadquartersCIMB HUB, Kuala Lumpur, Malaysia, 50250, Malaysia
- Websitehttps://duopharmabiotech.com
Leadership
- Mr. Wan Amir-Jeffery Bin Wan Abdul MajidCEO & Principal Executive Officer · b. 1972
- Ms. Rohayu Rosnani Binti Mohd AdananChief Financial Officer · b. 1980
- Mr. Ibrahim Hussin SallehChief Legal Officer & Group Company Secretary · b. 1968
- Ms. Sabrina Binti HaronChief Compliance Officer · b. 1981
- Mr. Krisnakumara ReddiChief Manufacturing & Sustainability Officer · b. 1970
- Mr. Shamsul Idham Bin A. IahadChief Consumer Healthcare Officer · b. 1974
- Mr. Wan Ahmad Nizam Bin Wan Mohd. SallehGroup Head of Risk Management & Integrity · b. 1974
- Ms. Priya Darshini AsokanChief Innovation Officer · b. 1983
- Ms. Noor Aida Binti JaafarChief Commercial Officer · b. 1975
Financials
Income Statement
Balance Sheet
Cash Flow
Earnings
Key Statistics & Ratios
Dividends
Stock Splits
- Sep 6, 20214:3
- Jun 14, 2018322782:138335
- Jun 18, 2015746:553
- Jul 12, 2004196106:89139
- Oct 8, 20036:5